Covered recipient · General Payments record
JORGE ASCONAPE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$117,198.66
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $15,400.00 | 7 |
| Travel and Lodging | $260.31 | 4 |
| Food and Beverage | $73.05 | 4 |
| Education | $16.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $15,733.36 | 15 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 08/14/2024 | Education | Undisputed | 01/23/2026 | 1144451205 | CMS |
| SK Life Science, Inc. | $2,800.00 | 03/19/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152759 | CMS |
| SK Life Science, Inc. | $53.98 | 03/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154152761 | CMS |
| SK Life Science, Inc. | $18.89 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154152763 | CMS |
| SK Life Science, Inc. | $700.00 | 03/22/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152775 | CMS |
| SK Life Science, Inc. | $700.00 | 03/22/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152785 | CMS |
| SK Life Science, Inc. | $2,800.00 | 04/30/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152741 | CMS |
| SK Life Science, Inc. | $66.33 | 04/30/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154152743 | CMS |
| SK Life Science, Inc. | $19.66 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154152745 | CMS |
| SK Life Science, Inc. | $2,800.00 | 05/24/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152749 | CMS |
| SK Life Science, Inc. | $74.34 | 05/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154152751 | CMS |
| SK Life Science, Inc. | $2,800.00 | 09/30/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152735 | CMS |
| SK Life Science, Inc. | $16.06 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154152737 | CMS |
| SK Life Science, Inc. | $65.66 | 12/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154152779 | CMS |
| SK Life Science, Inc. | $18.44 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154152781 | CMS |
| SK Life Science, Inc. | $2,800.00 | 12/02/2024 | Honoraria | Undisputed | 01/23/2026 | 1154152783 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.